Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
fuck shoulda bought at .028 when i discovered it and wanted to take a position. but i knew NOTHING of the company just the chart.
SPHE and MNDP have similar share structures to FTCH
MGLG... for about the last week or so i've noticed a slight reduction in avg volume. bollies are tightening. 0.0005 might be a good bid.
how would you like to wake up to this one morning:
HOUSTON, July 2, 2009 /PRNewswire-FirstCall via COMTEX/ -- Natural Nutrition (OTC: NTNI) announced today that the company has no explanation for the recent heavy trading in the company's stock, and specifically wishes to warn its shareholders that no positive news is pending or expected at this time from the company.
MNDP, A/H research report posted:
http://www.grassrootsrd.com/mndp-report.pdf
Cannabis Science Receives FDA Industry Guidelines for Mapping Out Its Initial Drugs Offerings for FDA Submission and Testing
2:35p ET July 28, 2009 (Market Wire)
Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to report that the FDA has provided the Company with documentation to assist the Company to review and plan its initial applications to get its first drug into formal testing.
Cannabis Science, Inc. President & CEO Dr. Robert Melamede stated, "After speaking directly with the FDA discussing our products and initiatives I was pleasantly surprised with the hands on approach they have with helping us map our path to get our products into testing. We have a ways to go, but I am very optimistic that we have an opportunity to have more than one product in testing and trials at the same time. We have an exciting new initiative we plan to announce shortly and I would like to thank our current and future shareholders for helping to make this happen."
Cannabis Science H1N1 Swine Flu Formulation:
We now know that the endocannabinoid system plays a critical role in maintaining human health. The human body produces Endocannabinoids on demand when they are needed. They help restore homeostasis (biochemical balance). The Cannabis plant produces Phytocannabinoids. When the human body has endocannabinoid deficiencies, it cannot effectively restore the healthy biochemical state needed to counter a particular illness. Phytocannabinoids from the Cannabis plant can replace the deficient endocannabinoid activity in the human body to restore a health-promoting level of cannabinoid activity. Cannabis Science will test its cannabis extract lozenge with FDA guidance and oversight to determine if it will reduce ARDS-associated deaths from both the Avian and Swine influenza infections.
H1N1 Swine Flu:
According to the CDC (http://www.cdc.gov/flu/avian/) the Avian flu (H5N1) has a 63% mortality rate. Unfortunately, the Swine flu, while causing death at a much lower rate than the Avian flu, appears to also result in death via a similar mechanism. The common cause of death with these strains is organ failure, especially as seen in the lungs with the development of Adult Respiratory Distress Syndrome (ARDS). ARDS is caused by an excess immune-generated inflammatory response that leads to apoptosis (cell death) and subsequently to organ failure. The Company's approach will mimic how the human body uses endocannabinoids (cannabinoids that occur naturally in the body) to regulate immune activity and cell survival, by regulating inflammatory biochemistry. Excessive inflammatory responses are associated with numerous disease states including autoimmune diseases, neurological imbalances, and cardiovascular disease. Phytocannabinoids provide a natural means to supplement illness-specific endocannabinoid deficiencies.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," "intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Cannabis Science Inc. Dr. Robert J. Melamede President & CEO Email Contact www.cannabisscience.com 1-888-889-0888 Catalyst Xchange Corp. Corporate Communications Donald Shaxon 1-866-216-3269 Brokers and Analysts: Wall Street International John Campo 1-410-236-8200
SOURCE: Cannabis Science, Inc.
http://www2.marketwire.com/mw/emailprcntct?id=520CCE389E02B502 http://www.cannabisscience.com
July 29, 2009 Conference calls:
LTFD
PHLI
FSRV
CTGX
i did a quick search, will look for more tonight
GRDO might be the next EXPH and hit penny land. I'm going to deposit some money and test her out!
Down 25%!!! saved $500 there, ha! first saw ibxg at .0005, damn i wish i woulda "bet blind" there
Tomorrow I bet it'll be up 50-100%, as much as I hate IBXG right now, it'll be a Green Friday, that I can almost guarantee.
meh... flat close, 38x40
theoretical buy, 500,000 @ $0.004-IBXG (.0036x.004) right now. lets see how that trade would have done EOD
PES G4 in a B6 S4 on the track
Aren't bear markets a bad thing though? I'd rather be in a Bull Market!!
EXPU - Expert Group
http://investorshub.advfn.com/boards/board.aspx?board_id=12049
discovered: 06/09/2009
call:
bid $0.098 06/09/2009
buy 7/8/2009
Posted by: lucab617
Date: Tuesday, July 07, 2009 12:50:48 PM
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39330722
Just called TA, SS is as follows:
AS - 100,000,000
OS - 33,380,583
Float - 11,519,080
ADNY - Adino Energy Corp
http://investorshub.advfn.com/boards/board.aspx?board_id=895
discovered = $0.022 7/5/2009
call = 7/5/2009
low = .015
SDGL - Secured Digital Applications Inc
http://investorshub.advfn.com/boards/board.aspx?board_id=2278
discovered = $0.013 7/5/2009
call = 7/5/2009
low = 0.009
LTHU - Lithium Technology Corp.
http://investorshub.advfn.com/boards/board.aspx?board_id=5511
Discovered = $0.03 7/1/2009
call = no call
High since = $0.03 7/2/2009
low since = $0.027 7/2/2009
Last close = $0.03 7/2/2009
SPCI - Sportsnuts
http://investorshub.advfn.com/boards/board.aspx?board_id=3960
discovered = $0.001 6/18/2009
call = no call
high since = $0.0025 6/19/2009
low since = $0.0011 6/30/2009 - 7/2/2009
last close = $0.0011 7/2/2009
IDGG - Indigo Energy
http://investorshub.advfn.com/boards/board.aspx?board_id=11078
discovered = $0.04 6/15/2009
call = no call
high since = $0.043 6/23/2009
low since = $0.028 7/2/2009
Last close = $0.03 7/2/2009
Followers
|
1
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
39
|
Created
|
07/02/09
|
Type
|
Free
|
Moderator Al_Capwn | |||
Assistants Clapabolic |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |